Three major healthcare groups are taking a stand against threats of violence over gender-affirming care by asking the Department of Justice to get involved. 

The criminal saga of the X-ray business owner who got caught fleecing CMS of $2 million—while grabbing for another $1.7 million or so—has reached its epilogue.

While Black women have lower incidence of breast cancer diagnosis, their mortality rates are 40% higher than those observed in white women.  

The recall is due to a malfunction risk that could, if not handled properly, cause the pump to stop working for a long period of time. This could lead to a serious injury or death, according to the recall. 

The Federal Aviation Administration assesses pilots for five “hazardous attitudes” that may forewarn of risky behaviors in the air. Therapeutic radiology researchers have adapted the FAA scale for radiation oncologists making treatment decisions.

The American Hospital Association (AHA) has claimed victory after the U.S. District Court for the District of Columbia ruled that the Department of Health and Human Services (HHS) must immediately halt payment cuts to the 340B Drug Pricing Program.

Patients face a risk of adverse events if they mistakenly take the wrong medication, according to a new warning from the FDA. 

Previously, CMS determined that coverage for patients receiving treatment was dependent on their being enrolled in a CMS-approved clinical trial under coverage with evidence development (CED).